HHZ Respiratory Review

CPAP Brands in India: Tier-by-Tier Landscape (2026)

The CPAP market in India in 2026 is dominated by ResMed, followed at a distance by Philips Respironics, with a cluster of mid-tier international brands (BMC, Fisher & Paykel, Lowenstein, Breas, Apex, Yuwell, DeVilbiss) and a growing set of Indian-channel brands (Oxymed, BPL, Deckmount, Wellel) competing primarily on price and local-service reachability. The decision of which brand to buy is not primarily a decision about turbine quality — at the therapy level, most of these devices produce clean pressure. The decision is about algorithm maturity, data-platform ecosystem, mask and humidifier compatibility, and, most importantly in the Indian context, what happens when something goes wrong.

This guide works through the brands by tier and tells you what each one is actually good at in the Indian market.

Tier 1: ResMed and Philips Respironics

ResMed (California; turbine assembly in Australia per product listings)

ResMed holds the dominant share of the Indian CPAP channel in 2026. The platforms that matter are the AirSense 10 family, AirSense 11 family, AirStart 10, AirCurve 10 family (BiPAP), AirMini (travel), and Lumis VPAP ST (home ventilation). Algorithm-wise, the AutoSet family is the most mature APAP algorithm in clinical use, the Vauto algorithm on the AirCurve 10 VAuto is the reference implementation of auto-bilevel titration, and iVAPS on the Lumis platform is one of the two main volume-targeted bi-level offerings available in India (alongside Philips AVAPS).

ResMed’s data platform — AirView for clinicians, myAir for patients — is the most developed in the market. Cellular connectivity or Bluetooth-to-phone (platform-dependent) pushes compliance data and residual-event data to the cloud without requiring patient intervention, which matters for physicians managing OSA patients remotely. This is the single largest practical advantage ResMed holds over lower-tier devices.

Indian service footprint: authorized dealers in all major metros, most tier-2 cities, and present-if-slow in tier-3. Warranty claim turnaround averages 7–14 days for in-warranty units. Out-of-warranty parts availability is strong — a 5-year-old AirSense 10 can typically get a replacement humidifier tub or power supply within a week.

Catalog representation in our reviews: AirSense 11 AutoSet, AirSense 10 AutoSet, AirStart 10 Auto, AirMini, AirCurve 10 VAuto BiPAP, AirCurve 10 ST, Lumis 100 VPAP ST, Lumis 150 VPAP ST.

Philips Respironics (Pennsylvania; turbine assembly in USA per product listings)

Philips Respironics was the co-dominant premium brand in India through roughly 2021, at which point the voluntary recall of DreamStation platforms over sound-abatement foam degradation reshuffled the Indian market. As of 2026, Philips is rebuilding Indian channel share with the DreamStation 2 platform and the DreamStation Auto BiPAP line. Algorithmically the Auto-Trak platform is mature; clinically the algorithms are effective.

The Care Orchestrator data platform parallels ResMed’s AirView in capability. The practical reality in 2026 is that more Indian prescribing physicians are set up on AirView than on Care Orchestrator, which tilts remote-management convenience toward ResMed by default. For patients whose prescriber is set up on Care Orchestrator, Philips is equivalent.

Indian service: post-recall remediation has strengthened the Philips service footprint in the metros; coverage in tier-2 and tier-3 cities remains uneven compared with ResMed. Parts availability is fine in metros.

Catalog representation: DreamStation Auto BiPAP, DreamStation BiPAP AVAPS.

Tier 2: BMC, Fisher & Paykel, Lowenstein, Breas

BMC (Beijing; China)

BMC is the most-sold non-tier-1 CPAP brand in India by unit volume, primarily because the RESmart GII platform prices below ₹18,000 and offers a functional APAP. The algorithms are standard-tier (no AutoSet-equivalent), the data platform (iCode, SD-card-based with QR-code compliance codes) is adequate but not remote-live like AirView, and the build is heavier than ResMed or Philips (2.5 kg typical vs 1.1–1.3 kg for the tier-1 platforms).

The BMC value proposition is price. For a patient who needs APAP therapy and whose alternative is no therapy at ResMed price points, BMC is the floor of the defensible Indian market. BMC also manufactures the M1 Mini travel CPAP and the Y30T bilevel platforms available through Indian channels.

Indian service: relies on distributor network — turnaround varies. Parts availability is generally acceptable in the metros; outside the metros expect 3–4 week service turnaround.

Catalog representation: RESmart GII Auto CPAP, M1 Mini Travel Auto CPAP, RESmart GII Y25T BiPAP, RESmart GII Y30T BiPAP, G3 B30VT BiPAP (with VAT).

Fisher & Paykel (Auckland, New Zealand)

Fisher & Paykel’s CPAP and bilevel platforms — SleepStyle, Icon+, and the premium ICON series — have never held large Indian channel share, primarily because the distribution and service footprint has been thinner than ResMed’s. F&P’s humidification engineering is genuinely excellent (the ThermoSmart heated humidifier is one of the best in the industry) and the SensAwake algorithm is differentiated. For the narrow set of Indian buyers who can access F&P service and want the humidification quality, it is a defensible choice. For most buyers, ResMed or Philips is easier to own.

Lowenstein Medical (formerly Weinmann; Germany)

Lowenstein’s Prisma platforms (Prisma20A APAP, Prisma Smart, Prisma25 ST bilevel) are high-quality German-engineered devices with strong algorithms. Indian channel penetration is modest. Service footprint is concentrated in a handful of authorized dealers in the metros. For buyers with access to one of those dealers and a preference for German engineering, Lowenstein is a legitimate premium option. For the average Indian buyer, the service reachability problem makes it a harder recommendation than ResMed.

Breas (Gothenburg, Sweden)

Breas’s primary Indian relevance is the Z2 Auto travel CPAP at ₹62,687, which competes with the ResMed AirMini in the travel-APAP category. The Z2 is a 300-gram device with waterless humidification, Z-Breathe expiratory relief, and Nitelog app connectivity via Bluetooth. It is FAA-approved, per published specs. Breas also makes home ventilators (Vivo platform) which see limited Indian consumer channel availability.

Tier 3: Apex, Yuwell, DeVilbiss

Apex (Taiwan)

Apex’s XT Auto and iCH II platforms are competently engineered APAPs that price similarly to BMC. Indian channel penetration is small but present in specific distributors. Algorithms are standard-tier. For buyers who happen to have an Apex dealer in reach and want an alternative to BMC at similar price, it is defensible.

Yuwell (Danyang, China)

Yuwell’s primary Indian footprint is in oxygen concentrators; CPAP presence in the Indian channel is thin. The YH-560 and YH-680 APAP platforms are available through some distributors. Algorithm quality is standard-tier. Service reachability is the limiter.

DeVilbiss Healthcare (Somerset, Pennsylvania)

DeVilbiss’s IntelliPAP 2 AutoAdjust is a competent mid-tier APAP. Indian channel penetration is small. Service footprint is thin. For buyers outside the metros, the service-reach question dominates the brand decision.

Indian-channel brands: Oxymed, BPL, Deckmount, Wellel

Oxymed (India-assembled; turbine imported per manufacturer brochure)

Oxymed’s CPAP lineup is the strongest Indian-channel value proposition in the budget-to-mid tier in 2026. The SleepEasy AutoCPAP at ₹28,499 uses a German turbine per manufacturer brochure, claims an advanced FlowSens algorithm with central-apnea detection, offers 3-year warranty with PAN-India home service, and includes cloud connectivity via mobile app. The AirSmart Bi-Level Auto at ₹33,990 extends the platform to auto-bilevel for OSA patients who do not tolerate CPAP. The AirSmart BPAP ST with VAPS at ₹37,490 delivers volume-assured bilevel therapy at a price point that no tier-1 brand matches.

The 3-year warranty with home service is genuinely differentiated and is the main reason Oxymed merits attention in the budget-to-mid bracket — most imported brands offer 2 years and require the customer to ship the unit to a service centre. For tier-2 and tier-3 city buyers whose nearest ResMed or Philips service centre is 200 km away, Oxymed’s service model is pragmatically superior, even if the algorithm is not as sophisticated as AutoSet.

BPL (Bengaluru, India)

BPL’s CPAP and bilevel line — Harmony Auto CPAP and LifePAP 25STA BiPAP — is Indian-manufactured. Published specs and features are competent mid-tier. The BPL Harmony Auto at ₹35,519 is a standard-tier APAP with leak compensation, detachable humidifier, and claimed 20,000-hour motor life per manufacturer brochure. The BPL LifePAP 25STA at ₹70,080 is a BiPAP ST with auto-EPAP and eVAPS (volume-assured) capability — a meaningful offering at this price.

BPL’s principal advantage is the direct-owned Indian service network, which is stronger in South India than in the North. For buyers in South Indian tier-2 cities (Madurai, Coimbatore, Mangalore, Kochi, Vizag), BPL’s service reach is genuinely better than any imported brand’s.

Deckmount (India)

Deckmount’s VT50 and VT200 platforms are Indian-manufactured with claimed made-in-India turbines per manufacturer brochure. The VT50 D Harmony Auto CPAP at ₹25,919 and the VT200 BiPAP with VAPS at ₹27,552 price aggressively. Algorithms are standard-tier; data platforms are SD-card plus QR-code compliance reporting. Service reachability depends on the distributor network. For buyers who prioritize Indian manufacture and are comfortable with standard-tier algorithm performance, Deckmount is a defensible option.

Wellel (Taiwan)

The Wellel iX Auto CPAP at ₹65,280 is a premium-priced Taiwanese APAP. Published specs claim an advanced algorithm with central-apnea detection, adaptive humidification, and cloud connectivity. Indian channel listings currently show the unit as out of stock in several outlets. The service footprint in India is thin. At this price point, the ResMed AirSense 11 AutoSet is the sharper buy by a wide margin.

Service network reality by brand

The Indian service-network reality in 2026, by brand:

Data-platform ecosystems

Remote clinical management is increasingly how Indian sleep physicians run their OSA practices. The data platform the device talks to is therefore a brand decision.

For patients whose sleep physician actively reviews data, a ResMed or Philips device is meaningfully more useful than an SD-card-only device. The cost delta is real but the adherence and outcome improvement from live remote management is real too.

Mask and humidifier compatibility

Mask compatibility is largely brand-agnostic at the functional level — any 22 mm hose will connect to any standard CPAP mask. But vendor-specific features matter:

Heated humidifier integration is proprietary. The ResMed HumidAir + ClimateLineAir combination automatically adjusts humidity based on ambient conditions and is part of why the AirSense platform runs well in both humid coastal Indian cities and dry North Indian winters. The Philips DreamStation humidifier is integrated similarly. The lower-tier platforms use decoupled heated humidifiers — they work, but without the automatic humidity adjustment.

Warranty claim reality per brand in India

Warranty terms on the brochure and warranty experience in practice are not always the same thing. Six years of Indian CPAP warranty claim patterns show the following:

ResMed: the 2-year standard warranty (3-year on the channel-discounted AirSense 10 AutoSet and 3-year on Lumis 150 per current product listings) is honored consistently. Claims are processed by the authorized dealer the patient purchased from, and the dealer interfaces with ResMed India for replacement. Turnaround 7–14 days in metros; 10–21 days in tier-2+. Fair interpretation of warranty scope: normal wear on humidifier seals and tubing excluded; turbine, power supply, mainboard, and display failures covered. Pressure-sensor drift (the most common age-related failure on 3–5 year old units) is occasionally the subject of warranty disputes — if the unit is within 2 years it is typically covered; after 2 years it is typically out-of-warranty and repair cost runs ₹8,000–₹15,000.

Philips Respironics: post-recall warranty administration has improved but is still heavier bureaucratically than ResMed’s. Turnaround 14–28 days is typical. Scope interpretation is similar. The 2021 recall fallout has not visibly affected standard warranty responsiveness on current DreamStation 2 platform devices.

BPL: domestic warranty with direct-owned service centres in South India produces the fastest turnaround of any Indian-market brand in that region — often same-week resolution. In North India, BPL service is distributor-channel with 10–21 day turnaround. Warranty scope is generally generous; BPL’s claim-denial rate is low.

Oxymed: the advertised 3-year PAN-India home service is real per manufacturer claim. Experience varies by distance from assembly base. Urban service in Tamil Nadu, Karnataka, Maharashtra is responsive (7–14 days). Tier-3 cities and Northeast India can see 21–30 day turnaround even on the home service model. Warranty-scope interpretation has been reported as generous by users — including some coverage of humidifier chamber replacement that is outside most imported-brand warranty scope.

BMC: warranty is administered through the Indian distributor. Metros 14–21 days; tier-2+ 21–35 days. Scope is standard (turbine, electronics, power supply); consumables and wear items excluded. Spares cost is reasonable — a replacement humidifier chamber is ₹2,500–₹3,500, which is lower than the ResMed equivalent at ~₹4,500.

Deckmount: warranty administration through the distributor. Reachability varies considerably by distributor. Patients in cities where the authorized Deckmount distributor has a service point experience prompt warranty resolution; outside those cities the experience degrades.

Wellel: the Indian service footprint is thin. Warranty claims require routing through the importer and can take 30+ days. This is the main argument against Wellel at its price point — the ResMed AirSense 11 at similar price has a dramatically better warranty experience.

F&P, Lowenstein, Breas, Apex, Yuwell, DeVilbiss: all thin on Indian warranty administration. Buyers should only consider these brands if they have confirmed an authorized service relationship locally before purchase.

The Indian channel pricing pattern per brand

Channel discount behaviour differs meaningfully by brand:

The MRP-vs-street-price gap in the Indian CPAP channel is large enough that never pay MRP is a reasonable rule. Quoted current prices in this review represent typical online channel pricing, not MRP.

Cross-device compatibility — masks, tubing, humidifier chambers

Some component interoperability is useful to understand:

22 mm universal tubing: any brand’s 22 mm smooth-bore tube works with any brand’s blower. Heated tubes are proprietary — ResMed ClimateLineAir only works with ResMed blowers; Philips heated tube only with Philips; F&P heated tube only with F&P.

Masks (with standard 22 mm connector): universally interoperable at the mechanical level. ResMed masks fit Philips blowers and vice versa. The only exception is the ResMed AirMini travel CPAP which uses a proprietary 15 mm tube and requires AirMini-specific masks.

Humidifier chambers: proprietary per platform. ResMed HumidAir 10 (AirSense 10) is not interchangeable with HumidAir 11 (AirSense 11); Philips DreamStation chambers are not interchangeable with DreamStation 2 chambers. Generic/aftermarket humidifier chambers exist on Indian channels at 30–50% of OEM cost, with mixed quality — the OEM chamber is the right buy.

Filters: mostly proprietary. ResMed filters fit only ResMed devices (different spec between AirSense 10 and 11); Philips filters are platform-specific. Aftermarket filters exist but mask-fit and filtration quality vary.

Power supplies: proprietary barrel connectors and voltages. A blown power supply on an out-of-warranty AirSense 11 is ₹18,000 to replace at authorized dealer; a generic equivalent (where available) is ₹2,500–₹4,000 but voids any remaining warranty and risks damaging the device if the spec is not matched precisely. The voltage-stabilizer investment mentioned in our APAP guide pays for itself many times over on power-supply preservation.

Final brand recommendation by buyer profile

The meta-point: for most Indian buyers in 2026, ResMed is the right answer for CPAP therapy. For buyers priced out of ResMed, Oxymed is the sharpest sub-₹30,000 value. BPL is the sharpest option for South India service. BMC is the price floor. Everything else is a niche case.